Anzeige
Mehr »
Login
Dienstag, 28.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Energiekrise als Chance: Mit dieser Aktie starten Sie ins Börsenjahr 2025 durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
547 Leser
Artikel bewerten:
(2)

ES Sunlogy Berhad Launches Prospectus For IPO On The ACE Market Of Bursa Securities

Finanznachrichten News

KUALA LUMPUR, MALAYSIA / ACCESS Newswire / January 27, 2025 / KUALA LUMPUR - ES Sunlogy Berhad ("ES Sunlogy" or the "Company"), an established provider of mechanical and electrical ("M&E") engineering services and renewable energy solutions, is pleased to announce the launch of its prospectus for the Initial Public Offering ("IPO") in conjunction with its listing on the ACE Market of Bursa Malaysia Securities Berhad ("Bursa Securities"). This marks a significant milestone in the Company's corporate journey, reinforcing its commitment to advancing Malaysia's infrastructure and energy transition.

From Left to Right:
1. Mr. Loh Kwang Yean?????, Independent Non-Executive Chairman, ES Sunlogy Berhad
2. Mr. Chu Kerd Yee ?????, Executive Director, ES Sunlogy Berhad
3. Mr. Khor Chuan Meng ?????, Managing Director, ES Sunlogy Berhad
4. Datuk Bill Tan ?????, Managing Director, M & A Securities Sdn Bhd
5. Datuk Keh Chuan Seng ?????, Promoter and Substantial Shareholder, ES Sunlogy Berhad
6. Ms. Rachel Ho Seow Leng ????, Deputy Head of Corporate Finance, M & A Securities Sdn Bhd
7. Ms. Jean Lim ?????,Associate Director of Corporate Finance, M & A Securities Sdn Bhd

The IPO is set to raise RM42.0 million through the issuance of 140.0 million new ordinary shares at a retail price of RM0.30 per share. The proceeds from the IPO will be allocated as follows:

  • RM14.1 million for the development and construction of the Selarong Large-Scale Solar Photovoltaic ("LSSPV") Plant, reinforcing the Company's focus on renewable energy.

  • RM14.0 million for the repayment of borrowings to strengthen its financial position.

  • RM9.2 million for general working capital to support its day-to-day operations.

  • RM0.7 million for the purchase of an enterprise resource planning ("ERP") system to enhance the Group's overall operational efficiency.

  • RM4.0 million for the IPO expenses.

Managing Director of ES Sunlogy Berhad, Mr. Khor Chuan Meng, stated, "The launch of our prospectus is a proud moment for ES Sunlogy, marking a new chapter in our growth and corporate journey. This IPO will enable us to further accelerate our efforts in delivering high-quality M&E engineering solutions while advancing Malaysia's renewable energy agenda. The funds to be raised from our IPO will support our long-term strategic initiatives, including expanding our capabilities in the renewable energy sector, strengthening our financial position, enhancing operational efficiency, improving our visibility and contributing to the nation's sustainable development. This listing reflects our long-term commitment to innovation, sustainability, and delivering long-term value to our stakeholders."

ES Sunlogy Berhad has demonstrated strong financial performance, with total revenue increasing by RM85.91 million, or 169.0%, from RM50.82 million in the financial year ended ("FYE") 2022 to RM136.73 million in FYE 2023. This growth continued in FYE 2024, with revenue increasing further by RM54.36 million, or 39.8%, to RM191.09 million. This stellar performance underscores the Company's strategic focus on expanding M&E services across high-demand sectors, including solar installations and industrial energy solutions, with key M&E projects in Selangor, Johor, Perak, Kedah, Penang, Negeri Sembilan and Perlis.

Looking forward, ES Sunlogy remains committed to its role as a leader in Malaysia's renewable energy transition. By delivering solar solutions for residential and commercial properties, providing customised energy systems for industrial clients, and supplying sustainable energy solutions for industrial sectors, the Company supports energy savings and sustainability. These initiatives, combined with its participation in large-scale programmes such as LSS5, align with its vision to grow its market share, expand regionally, and contribute meaningfully to Malaysia's sustainability and green energy goals.

The launch was graced by the presence of ES Sunlogy Berhad's three key promoters, namely Mr. Khor Chuan Meng, Managing Director; Mr. Chu Kerd Yee, Executive Director; and Datuk Keh Chuan Seng, Promoter and Substantial Shareholder. Their participation highlighted the significant role of their leadership and vision in the company's journey towards its listing on the ACE Market.

M & A Securities Sdn. Bhd. is the Principal Adviser, Sponsor, Underwriter, and Placement Agent for this IPO.

ABOUT ES SUNLOGY BERHAD

ES Sunlogy Berhad ("ES Sunlogy" or the "Company") is an established provider of mechanical and electrical ("M&E") engineering services, specialising in electrical engineering services for electricity supply distribution systems, mechanical engineering services for building services, as well as generation and sales of renewable energy. The Company and its subsidiaries (collectively, the "Group") has an extensive portfolio of projects across Malaysia, including industrial, commercial and residential properties, and solar facilities. ES Sunlogy has established itself as a trusted name in delivering innovative, efficient, and high-quality engineering solutions. The Group is committed to contributing to Malaysia's sustainable energy landscape with its focus on solar energy projects and renewable energy solutions.

For more information, visit www.essunlogy.com.

Issued By: Swan Consultancy Sdn. Bhd. on behalf of ES Sunlogy Berhad

For more information, please contact:

Jazmin Wan

Email: j.wan@swanconsultancy.biz

Mandy Tan

Email: m.tan@swanconsultancy.biz

SOURCE: ES Sunlogy Berhad



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.